These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25550857)

  • 1. Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.
    Zhang X; Dang Y; Li P; Rong M; Chen G
    Int J Clin Exp Pathol; 2014; 7(11):8096-104. PubMed ID: 25550857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
    World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of tumor necrosis factor receptor-associated factor 6 in lung cancer tissues.
    Zhang XL; Dang YW; Li P; Rong MH; Hou XX; Luo DZ; Chen G
    Asian Pac J Cancer Prev; 2014; 15(24):10591-6. PubMed ID: 25605144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of EGFR, survivn and hnRNPA2/B1 in bronchial brushing cytology specimens and their significance in diagnosis of lung cancer].
    Lu SS; Pan QJ; Zhao LL; Guo HQ; Zhang ZH; Cao J
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):621-5. PubMed ID: 22325225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological and prognostic significance of ERα and ERβ expression in lung carcinomas: a tissue microarray study].
    Yang X; Xue LY; Liu Y; Guo L; Wen P; Lin DM
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):678-83. PubMed ID: 24332055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
    Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
    Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
    Chang C; Wang P; Yang H; Li L; Zhang LB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OTUD7B and NIK expression in non-small cell lung cancer: Association with clinicopathological features and prognostic implications.
    Zhang B; Wang H; Yang L; Zhang Y; Wang P; Huang G; Zheng J; Ren H; Qin S
    Pathol Res Pract; 2016 Oct; 212(10):893-898. PubMed ID: 27499151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer].
    Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM
    Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study.
    Liu B; Wan Z; Sheng B; Lin Y; Fu T; Zeng Q; Qi C
    BMC Pulm Med; 2017 Dec; 17(1):214. PubMed ID: 29282042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of caveolin-1 expression in primary lung cancer].
    Yu JH; Wei Q; Qi FJ; Xu HT; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):664-8. PubMed ID: 17374210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.
    Zhang K; Chen L; Deng H; Zou Y; Liu J; Shi H; Xu B; Lu M; Li C; Jiang J; Wang Z
    Int J Clin Exp Pathol; 2015; 8(1):629-35. PubMed ID: 25755755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
    Fan W; Yang H; Xue H; Sun Y; Zhang J
    Int J Clin Exp Pathol; 2015; 8(5):5503-8. PubMed ID: 26191257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
    Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of Smac in Stage I-II non-small cell lung cancer and its clinical significance].
    Zhao JM; Zhu ZH; Wu QL; Hou JH; Huang XP; Zhang PY; Rong TH
    Ai Zheng; 2006 May; 25(5):631-4. PubMed ID: 16687088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of c-erbB-2 and loss of p16 have molecular diagnostic relevance but no prognostic value in lung cancer.
    Feng XL; Li L; Gao YN; Zhang JJ; Xiao T; Ying JM; Gao JD; Sun YT; Cheng SJ
    Med Oncol; 2011 Mar; 28(1):336-41. PubMed ID: 20237870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CXCR4 and Nrf2 expressions in non-small cell lung cancer and their clinical implications].
    Hu T; Yao Y; Yu S; Guo H; Tian T; Han L; Wang W; Guo Q; Wang J; Nan K; Wang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):153-8. PubMed ID: 24589587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.